is a Partner in the Washington, DC office of Schiff Hardin. John has deep experience in intellectual property litigation and regularly litigates patent infringement and trade secret cases. Since 2006 his practice has focused on pharmaceutical litigation, representing generic drug manufacturers in high-stakes patent litigation brought under the Hatch-Waxman Act. With a Ph.D. in chemistry, John’s depth of scientific knowledge makes him uniquely qualified to advise his pharmaceutical clients and develop trial strategies for effective trial presentations or negotiating favorable settlements.
For more information or to contact John, please visit his Firm Profile Page.